CARGO Therapeutics Inc. C...
12.08
0.90 (8.05%)
At close: Jan 15, 2025, 3:59 PM
12.04
-0.33%
After-hours Jan 15, 2025, 04:04 PM EST

CARGO Therapeutics Common Stock Statistics

Share Statistics

CARGO Therapeutics Common Stock has 46.03M shares outstanding. The number of shares has increased by 16.93% in one year.

Shares Outstanding 46.03M
Shares Change (YoY) n/a
Shares Change (QoQ) 0.27%
Owned by Institutions (%) n/a
Shares Floating 32.06M
Failed to Deliver (FTD) Shares 1.48K
FTD / Avg. Volume 0.64%

Short Selling Information

The latest short interest is 6.05M, so 13.14% of the outstanding shares have been sold short.

Short Interest 6.05M
Short % of Shares Out 13.14%
Short % of Float 18.86%
Short Ratio (days to cover) 25.13

Valuation Ratios

The PE ratio is -9.72 and the forward PE ratio is -4.54.

PE Ratio -9.72
Forward PE -4.54
PS Ratio 0
Forward PS 12.1
PB Ratio 2.35
P/FCF Ratio -10.58
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for CARGO Therapeutics Inc. Common Stock.

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 19.35, with a Debt / Equity ratio of 0.

Current Ratio 19.35
Quick Ratio 19.35
Debt / Equity 0
Total Debt / Capitalization 0
Cash Flow / Debt 0
Interest Coverage -60.29

Financial Efficiency

Return on equity (ROE) is -0.24% and return on capital (ROIC) is -22.29%.

Return on Equity (ROE) -0.24%
Return on Assets (ROA) -0.22%
Return on Capital (ROIC) -22.29%
Revenue Per Employee 0
Profits Per Employee -577.34K
Employee Count 170
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -42.46% in the last 52 weeks. The beta is 0, so CARGO Therapeutics Common Stock's price volatility has been lower than the market average.

Beta 0
52-Week Price Change -42.46%
50-Day Moving Average 16.51
200-Day Moving Average 18.18
Relative Strength Index (RSI) 31.59
Average Volume (20 Days) 230.06K

Income Statement

Revenue n/a
Gross Profit -3.69M
Operating Income -96.71M
Net Income -98.15M
EBITDA -93.02M
EBIT n/a
Earnings Per Share (EPS) -2.38
Full Income Statement

Balance Sheet

The company has 405.73M in cash and 28.54M in debt, giving a net cash position of 377.19M.

Cash & Cash Equivalents 405.73M
Total Debt 28.54M
Net Cash 377.19M
Retained Earnings -145.15M
Total Assets 450.96M
Working Capital 388.38M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -81.16M and capital expenditures -8.99M, giving a free cash flow of -90.16M.

Operating Cash Flow -81.16M
Capital Expenditures -8.99M
Free Cash Flow -90.16M
FCF Per Share -2.19
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRGX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -21.21%
FCF Yield -17.46%
Dividend Details

Analyst Forecast

The average price target for CRGX is $32.5, which is 189.7% higher than the current price. The consensus rating is "Buy".

Price Target $32.5
Price Target Difference 189.7%
Analyst Consensus Buy
Analyst Count 6
Stock Forecasts

Scores

Altman Z-Score 7.3
Piotroski F-Score 2